MedTrace Logo

Telerehabilitation Program Bases Aerobic and Baduanjin Exercises in Post Stroke Elderly Patients

NCT06278259 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-08-13

No results posted yet for this study

Summary

It is an interventional study in which 68 stroke patients are estimated to be enrolled according to random allocation and will be divided into two groups. The study group participants will be involved in Telerehabilitation sessions, which will be based on aerobic exercises, guided by video with the Baduanjin exercise program; the control group will receive the same aerobic exercises only

Conditions

Interventions

OTHER

Telerehabilitation program bases aerobic and Baduanjin exercises

It is an interventional study in which 68 stroke patients are estimated to enroll according to random allocation and divided into two groups. The study group participants involve in Telerehabilitation sessions is based on aerobic exercises, guided by video. The telerehabilitation program is aerobic exercise 3 times per week for 3 months. With the Baduanjin exercise program is delivered individually, at each patient's home, through telerehabilitation, with direct remote supervision by a physiotherapist

OTHER

Telerehabilitation program bases aerobic exercises

The telerehabilitation program is aerobic exercise 3 times per week for 3 months.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • marwa elsayed, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2025-11-28
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06278259 on ClinicalTrials.gov